مورد إلكتروني
Gender Differences in Healthy Lifestyle Adherence Following Percutaneous Coronary Intervention for Coronary Artery Disease.
| العنوان: | Gender Differences in Healthy Lifestyle Adherence Following Percutaneous Coronary Intervention for Coronary Artery Disease. |
|---|---|
| بيانات النشر: | Elsevier Ltd United Kingdom 2021-03-13 |
| تفاصيل مُضافة: | Cameron J. Perera S. Aslam A. Stehli J. Kaye D. Layland J. Nicholls S.J. Zaman S. |
| نوع الوثيقة: | Electronic Resource |
| مستخلص: | Background: Coronary artery disease (CAD) is the leading cause of mortality in Australian women. We identified gender differences in healthy lifestyle adherence in patients treated with percutaneous coronary intervention (PCI) for CAD. Method(s): Consecutive patients were prospectively recruited from three Australian institutions (2016-2017). The primary endpoint at 1 year follow-up was healthy lifestyle adherence defined as 3/3 of: a heart-healthy diet, being physically active and not smoking. Secondary endpoints included cardiac rehabilitation attendance, medication use and lipid levels. Result(s): From 729 participants (n=192, 26.3% women) 56% were adherent to all three lifestyle measures with no gender difference overall. Compared to men, women were less likely to smoke (7.7% versus 12.2%, p<0.001) to be physically active (61.5% versus 78.2%; p<0.0001), attend cardiac rehabilitation (58.2% versus 66.4%; p<0.045), and take statin therapy (85.4% versus 94.7%; p<0.0001). Female gender independently predicted physical inactivity (OR 2.41, 95% CI 1.57-3.68, p<0.001). Conclusion(s): Important gender differences exist in patients treated with PCI for CAD, namely, significant lower physical activity, cardiac rehabilitation attendance and statin use in women. These all represent key targets for gender-specific secondary prevention interventions.Copyright © 2020 |
| مصطلحات الفهرس: | controlled study, coronary artery disease/dt [Drug Therapy], coronary artery disease/rh [Rehabilitation], coronary artery disease/th [Therapy], drug use, female, follow up, healthy diet, healthy lifestyle, heart rehabilitation, human, lipid blood level, lipoprotein blood level, major clinical study, male, middle aged, non ST segment elevation myocardial infarction/rh [Rehabilitation], non ST segment elevation myocardial infarction/th [Therapy], percutaneous coronary intervention, physical activity, physical inactivity, aged, prediction, priority journal, prospective study, sex difference, smoking, ST segment elevation myocardial infarction/rh [Rehabilitation], ST segment elevation myocardial infarction/th [Therapy], stable angina pectoris/rh [Rehabilitation], stable angina pectoris/th [Therapy], triacylglycerol blood level, unstable angina pectoris/rh [Rehabilitation], unstable angina pectoris/th [Therapy], acetylsalicylic acid/dt [Drug Therapy], angiotensin receptor antagonist/dt [Drug Therapy], antithrombocytic agent/dt [Drug Therapy], cholesterol/ec [Endogenous Compound], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], ezetimibe/dt [Drug Therapy], high density lipoprotein/ec [Endogenous Compound], hydroxymethylglutaryl coenzyme A reductase inhibitor/dt [Drug Therapy], lipid/ec [Endogenous Compound], Australia, thienopyridine derivative/dt [Drug Therapy], ticagrelor/dt [Drug Therapy], triacylglycerol/ec [Endogenous Compound], adult, low density lipoprotein cholesterol/ec [Endogenous Compound], cholesterol blood level, article, Article |
| URL: | Heart Lung and Circulation LibKey Link |
| الإتاحة: | Open access content. Open access content Copyright 2021 Elsevier B.V., All rights reserved. |
| أرقام أخرى: | AUSHL oai:repository.monashhealth.org:1/26999 Heart Lung and Circulation. 30 (1) (pp e37-e40), 2021. Date of Publication: January 2021. 1443-9506 https://repository.monashhealth.org/monashhealthjspui/handle/1/26999Test 32843294 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32843294Test] 2007560886 (Perera, Aslam) Department of Medicine, Monash University, Melbourne, Vic, Australia (Stehli, Nicholls, Cameron, Zaman) Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia (Stehli, Kaye) Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia (Kaye) Division of Cardiovascular, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia (Layland) Department of Cardiology, Peninsula Health, Melbourne, Vic, Australia (Layland) Peninsula Clinical School, Monash University, Melbourne, Vic, Australia (Nicholls, Cameron, Zaman) MonashHeart, Monash Medical Centre, Melbourne, Vic, Australia Zaman S.; sarah.zaman@monash.edu (Perera, Aslam) Department of Medicine, Monash University, Melbourne, Vic, Australia (Stehli, Nicholls, Cameron, Zaman) Monash Cardiovascular Research Centre, Monash University, Melbourne, Vic, Australia (Stehli, Kaye) Department of Cardiology, Alfred Hospital, Melbourne, Vic, Australia (Kaye) Division of Cardiovascular, Baker Heart and Diabetes Institute, Melbourne, Vic, Australia (Layland) Department of Cardiology, Peninsula Health, Melbourne, Vic, Australia (Layland) Peninsula Clinical School, Monash University, Melbourne, Vic, Australia (Nicholls, Cameron, Zaman) MonashHeart, Monash Medical Centre, Melbourne, Vic, Australia 1305123010 |
| المصدر المساهم: | MONASH HEALTH LIBRS From OAIster®, provided by the OCLC Cooperative. |
| رقم الانضمام: | edsoai.on1305123010 |
| قاعدة البيانات: | OAIster |
| الوصف غير متاح. |